noom with glp 1 π¨ INTRODUCING: Proactive Health Microdose GLP-1β Go beyond the prescription! Pair
Description
About 50% of prescriptions for GLP-1s in 2024 were intended for weight loss, according to Fair Health
Drinking alcohol during these transition weeks may increase the risk of severe vomiting and diarrhea

, Giovino, G

Yes, patients with type 2 diabetes should be monitored for hypoglycaemia, especially if taking insulin or sulfonylureas alongside Wegovy

Both are legitimate options

If pancreatitis is suspected, Wegovy should be discontinued and appropriate diagnostic tests performed urgently Gallbladder problems : Rapid weight loss increases risk of gallstone formation, with cholelithiasis reported in approximately 1.6% of Wegovy users Intestinal obstruction/ileus : Cases have been reported in post-marketing surveillance, particularly in patients with pre-existing GI conditions Management strategies recommended by healthcare professionals include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, spicy, or heavily processed foods Staying well-hydrated, particularly if experiencing diarrhoea or vomiting, to prevent dehydration and potential acute kidney injury Not lying down immediately after eating to minimise reflux Ensuring adequate fibre intake to prevent constipation Taking the medication on the same day each week to maintain steady levels Most GI side effects improve over time as the body adjusts to the medication, typically becoming less troublesome after 4-8 weeks at each dose level
